Residential Treatment Center Level 3.5 denials in California external review
In the California DMHC record, independent physician reviewers decided 18 published external-review cases involving Residential Treatment Center Level 3.5and overturned the plan’s denial in 55.6%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.
Conditions behind Residential Treatment Center Level 3.5 denials
| Category | Decisions | Overturned |
|---|---|---|
| Alcohol Use Disorder | 10 | 50% |
| Opioid Use Disorder | 6 | 83.3% |
| Methamphetamine Use Disorder | 5 | 60% |
| Post-traumatic Stress Disorder | 3 | 66.7% |
| Cannabis Use Disorder | 3 | 66.7% |
What the reviewers wrote
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement and prospective authorization and coverage for any or all of the residential treatment center (ASAM 3.5) level of care services. Per American Society of Addiction Medicine (ASAM) criteria, this patient met Level 3.5 criteria for RTC services from 5/14/23 and forward. ASAM criteria focuses on six dimensions to determine the appropriate level of care, which includes: (1) intoxication and withdrawal potential; (2) biomedical conditions; (3) emotional, behavioral and cognitive conditions; (4) readiness to change; (5) relapse, continued use, or continued problem potential; and (6) recovery environment. For dimension 1, the patient did not have symptoms of withdrawal following detoxification. The patient’s withdrawal needs are safely managed in a Level 3.5 setting.
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement and prospective authorization and coverage for residential treatment center (RTC) (ASAM 3.5) level of care services. Findings: The physician reviewer found that the American Society of Addiction Medicine (ASAM) criteria, this patient meets Level 3.5 criteria for RTC level of care services. ASAM criteria focuses on six dimensions to determine the appropriate level of care, which includes: (1) intoxication and withdrawal potential; (2) biomedical conditions; (3) emotional, behavioral, and cognitive conditions; (4) readiness to change; (5) relapse, continued use, or continued problem potential; and (6) recovery environment.For dimension 1, the patient did not have any symptoms of withdrawal after he completed detoxification services.
Where the denial was upheld
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for residential treatment center (RTC) (ASAM 3.5) level of care services. Per the American Society of Addiction Medicine (ASAM) criteria, this patient did not meet Level 3.5 criteria for RTC services for the time period under review. The ASAM criteria focus on six dimensions to determine the appropriate level of care, which includes: (1) intoxication and associated risk, withdrawal and associated risks, and addiction medication needs; (2) biomedical conditions including physical health concerns and pregnancy-related concerns; (3) psychiatric and cognitive conditions and history including active psychiatric symptoms and persistent disability; (4) substance-use-related risks including the likelihood of engaging in risky substance use and the likelihood of engaging…
Nature of Statutory Criteria/Case Summary: The enrollee has requested reimbursement for Residential Treatment Center (ASAM 3.5) level of care services. Findings: The physician reviewer found that California Health and Safety Code section 1374.72(a)(3)(A) states that “Medically necessary treatment of a mental health or substance use disorder” means a service or product addressing the specific needs of that patient, for the purpose of preventing, diagnosing, or treating an illness, injury, condition, or its symptoms, including minimizing the progression of that illness, injury, condition, or its symptoms, in a manner that is all of the following:(i) In accordance with the generally accepted standards of mental health and substance use disorder care.(ii) Clinically appropriate in terms of type, frequency, extent, site, and duration.(iii) Not primarily for the economic benefit of the health…
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Residential Treatment Center Level 3.5, then check the rights and deadlines that apply to your plan.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY